Hasil Pencarian  ::  Simpan CSV :: Kembali

"Tujuan :Untuk mengetahui apakah ada perbedaan hasil pengukuran tekanan intraokular sebelum dan sesudah lindakan laser-assisted in situ keratomileusis (LASIK).Subyek dan metode :Penelitian ini merupakan uji klinis analitik dengan desain pre post .study. Penderita yang memenuhi kriteria inklusi dan menjalani bedah LASIK dibagi ke dalam dua kelompok, yaitu kelompok dengan nilai spherical equivalent (SE) < 6 dioptri (D) dan kelompok SE 6 D. Parameter yang dinilai adalah tekanan intraokular (T1O) yang diperiksa dengan alat Tonopen dan ketebalan komea sebelum dan minimal 4 minggu sesudah bedah LASIK.Hasil :Hasil pengukuran tekanan intraokular sebelum LASIK pada kelompok SE < 6 D adalah 13.10 ± 2.05 mmHg, dan pada kelompok SE ? 6 D adalah 13,05 } 2,69 rrunHg. Hasil pengukuran tekanan intraokular sesudah LASIK pada kelompok SE < 6 D adalah 11.70 f 1,49 mmHg. dan pada kelompok SE 6 D adalah 10,50 ± 1,00 mmHg. Hasil pengukuran TIO sesudah LASIK lebih rendah dibandingkan sebelum LASIK dan secara statistik bermakna. Selisih basil pengukuran tekanan intraokular sebelum - sesudah LASIK kelompok SE 6 D (2,55 ± 2,32 mmHg) lebih besar dibandingkan kelompok SE < 6 D (1,40 = 1,30 mmHg) dengan p=0,06. Kesimpulan :Tindakan bedah refraktif LASIK akan mengurangi ketebalan kornea dan merubah rigiditas kornea sehingga mempengaruhi hasil pengukuran tekanan intraokular.

---

Purpose :

To evaluate the intraocular pressure (IOP) measurement with Tonopen before and after laser-assisted in situ keratommileusis (LASIK).

Patients and Methods :

In a prospective study of clinic-based population undergoing elective LASIK surgery for myopia correction, lOP measurements were obtained preoperatively and postoperatively with Tonopen. Central corneal thickness was also obtained before and after surgery. Subject were assigned into two groups, spherical equivalent (SE) less than 6 dioptri (D) and 6 D above.

-Results

Four weeks after LASIK, mean IOP in two groups were lower than before surgery (P=0,00), as measured by Tonopen were 11,70 * 1,49 mmHg (SE < D) and 10,50 ± 1,00 mmHg (SE > 6 D). The mean 1OP reduction in SE a 6 D was higher than in SE < 6 D (2,55 ± 2,32 mmHg, 1,40 ± 1,30 mmHg, respectively, p=0.06).

Conclusion :

After LASIK, corneal thickness and corneal rigidity were reduced, causing it to undervalue IOP."

"Tujuan: membandingkan penurunan TIO setelah pemberian obat tetes mata travoprost 0,004% dengan penurunan TIO setelah pemberian timomol 0,5% pada glaukoma primer sudut tertutup kronis (GPSTp kronis).Metode: penelitian ini merupakan penelitian prospektif, randomisasi, dengan cross over design pada 32 mata dari 16 subjek GPSTp kronis. Subyek dibagi menjadi 2 kelompok: kelompok travoprost dan kelompok timolol. Masing-masing kelompok terdiri dari 8 subyek. Dua minggu setelah pemberian obat, dilakukan penyilangan kelompok. Tekanan intraocular diukur sebelum terapi, dan pada hari ke-1, hari ke-7, hari ke-14 setelah terapi. Periode wash out dilakukan pada saat sebelum diberikan perlakukan dan setelah cross over. Setiap wash out berlangsung selama 3 minggu.Hasil: Kelompok travoprost mempunyai TIO awal rerata 25,38±2,55 mmHg, penurunan TIO mencapai 11,44±2,55 mmHg, penurunan TIO mencapai 6,63±2,25 mmHg. Dengan uji statistic, travoprost menurunkan TIO lebih besar dibandingkan timolol secara bermakna (p<0,05)Kesimpulan: Obat tetes mata travoprost 0,004% menunrunkan TIO lebih besar dibandingkan obat tetes mata timolol 0,5%.

---

Objective: To compare the reduction of intraocular after taking travoprost VS timolol in chronic primary angle-closure glaucoma.

Method: We performed a prospective, randomized, crossover study of 32 eyes of 16 patients with chronic primary angle-closure glaucoma. Patients were randomized to 2 group: those taking travoprost once daily or those taking timolol twice daily. Each group comprise of 8 patients. Two weeks after treatment with the first drug, the second drug was substituted. Intraocular pressure (IOP) was recorded before the start of therapy, at day 1, at day 7, and at day 14. Wash out period conducted prior to initial treatment and after the cross over. The duration of wash out period was three weeks.

Results: The mean baseline IOP was 25.38±3.01 mmHg, which decreased by 11.44±1.90 mmHg with travoprost. The mean baseline IP was 25.88±2.55 mmHg, which decreased by 6.63±2.25 mmHg with timolol. By statistic test, travoprost reduced the IOP greater than timolol significantly (p<0.05).

Conclusion: 0.004% travoprost eyedrops reduce the IOP greater than 0.5timolol eyedrops."

"ABSTRAK Latar belakang Glaukoma masih merupakan salah satu penyebab kebutaan terbesar di dunia. Belakangan ini, ketebalan RFNL dan GCIPL diketahui memilikihubungan terhadap perubahan struktural yang disebabkan oleh glaukoma. Tujuan untuk mengkaji kemampuan diagnostik dari pengukuran ketebalan RFNLdan GCIPL dalam mendeteksi glaukoma pada tahap awal.Metode Enam puluh empat mata dengan sudut bilik mata sempit (32 glaukoma,32 non-glaukoma) dari 48 pasien menjalani pengukuran menggunakan CirrusOCT dengan protokol 3,4 mm pemindaian cepat RFNL peripapilar. Pengukurandilakukan pada sisi superior, inferior, nasal, temporal dari GCIPL dan RFNL,begitu juga dengan GCIPL superotemporal, superonasal, inferotemporal,inferonasal, dan minimal. Hasil Semua parameter yang diuji pada studi ini menunjukkan angka yang lebihrendah pada kelompok PACG dibandingkan kelompok PAC. Rerata ketebalanRFNL dan ketebalan GCIPL inferotemporal masing-masing memiliki nilaispesifitias dan sensitifitas yang paling baik. Parameter dengan determinan terbaikadalah ketebalan GCIPL inferotemporal dengan sensitifitas dan spesifitas masingmasing75%dan75%.KesimpulanKetebalan GCIPL dan RFNL peripapil memiliki potensi besarsebagai parameter diagnostik seperti skrining dan evaluasi respon terapi.ABSTRACT Background Glaucoma remains one of the biggest causes of blindnessworldwide. Recently, RFNL and GCIPL thickness were shown to be correlatedwith early structural changes caused by glaucoma. Objective to evaluate the diagnostic performance of RFNL and GCIPL thicknessmeasurement in detecting early glaucoma Method Sixty-four eyes with primary angle closure (32 glaucomatous, 32 nonglaucomatous)of48patients underwent peripapillar scanning using Cirrus OCTusing 3,4 mm protocol fast RNFL peripapillary thickness scan. The measurementincludes superior, inferior, nasal, temporal, mean GCIPL and RFNL, as well assuperotemporal, superonasal, inferotemporal, inferonasal, minimal GCIPL. Result All parameters studied were significantly thinner in PACG groupcompared to PAC group. Mean RFNL thickness and inferotemporal GCIPL hasthe highest specificity and sensitivity, respectively, in detecting glaucoma.Parameter with the best determinant is inferotemporal GCIPL thickness withsensitivity and specificity, 75% and 71.9%, respectively. Conclusion Peripapillary RFNL and GCIPL could be a potential diagnosticparameter in detecting early glaucoma and monitoring therapy response inglaucoma patients. ;Background Glaucoma remains one of the biggest causes of blindnessworldwide. Recently, RFNL and GCIPL thickness were shown to be correlatedwith early structural changes caused by glaucoma. Objective to evaluate the diagnostic performance of RFNL and GCIPL thicknessmeasurement in detecting early glaucoma Method Sixty-four eyes with primary angle closure (32 glaucomatous, 32 nonglaucomatous)of48patients underwent peripapillar scanning using Cirrus OCTusing 3,4 mm protocol fast RNFL peripapillary thickness scan. The measurementincludes superior, inferior, nasal, temporal, mean GCIPL and RFNL, as well assuperotemporal, superonasal, inferotemporal, inferonasal, minimal GCIPL. Result All parameters studied were significantly thinner in PACG groupcompared to PAC group. Mean RFNL thickness and inferotemporal GCIPL hasthe highest specificity and sensitivity, respectively, in detecting glaucoma.Parameter with the best determinant is inferotemporal GCIPL thickness withsensitivity and specificity, 75% and 71.9%, respectively. Conclusion Peripapillary RFNL and GCIPL could be a potential diagnosticparameter in detecting early glaucoma and monitoring therapy response inglaucoma patients. ;Background Glaucoma remains one of the biggest causes of blindnessworldwide. Recently, RFNL and GCIPL thickness were shown to be correlatedwith early structural changes caused by glaucoma. Objective to evaluate the diagnostic performance of RFNL and GCIPL thicknessmeasurement in detecting early glaucoma Method Sixty-four eyes with primary angle closure (32 glaucomatous, 32 nonglaucomatous)of48patients underwent peripapillar scanning using Cirrus OCTusing 3,4 mm protocol fast RNFL peripapillary thickness scan. The measurementincludes superior, inferior, nasal, temporal, mean GCIPL and RFNL, as well assuperotemporal, superonasal, inferotemporal, inferonasal, minimal GCIPL. Result All parameters studied were significantly thinner in PACG groupcompared to PAC group. Mean RFNL thickness and inferotemporal GCIPL hasthe highest specificity and sensitivity, respectively, in detecting glaucoma.Parameter with the best determinant is inferotemporal GCIPL thickness withsensitivity and specificity, 75% and 71.9%, respectively. Conclusion Peripapillary RFNL and GCIPL could be a potential diagnosticparameter in detecting early glaucoma and monitoring therapy response inglaucoma patients. "

"[ABSTRAKTujuan : Mengevaluasi ada tidaknya perbedaan kualitas air mata pada penderita glaukoma yangmengalami mata kering antara yang diberi tetes mata sodium hialuronat 0,1% mengandung bahanpengawet benzalkonium klorida dan tetes mata sodium hialuronat 0,1% tanpa bahan pengawet.Metode : Penelitian ini merupakan penelitian prospektif terandomisasi. 30 pasien glaukoma yangmengalami mata kering dirandomisasi ke dalam kedua kelompok. Kelompokpertama,mendapatkan obat tetes mata artificial tear mengandung sodium hialuronat 0,1% denganpengawet benzalkonium klorida, sedangkan kelompok II, mendapatkan obat tetes mata artificialtear mengandung sodium hialuronat 0,1% tanpa pengawet selama 1 bulan. Pemeriksaan Schirmertest, TFBUT, OPI, dan sitologi impresi dilakukan pada kedua kelompok baik sebelum dan sesudah1 bulan penetesan obat tetes mata artificial tear.Results: Nilai median sitologi impresi sel goblet pasca penetesan artificial tear meningkat padakelompok I (118,15-485) dan kelompok II (67.0-200), namun secara statistik tidak ada perbedaanbermakna. Nilai rata ? rata TFBUT pasca penetesan pada kelompok I (14,45±7,85) dan kelompokII (13,91±7,46) meningkat dibandingkan sebelum penetesan, serta secara statitstik memilikiperbedaan yang bermakna. Nilai Schirmer test dan OPI pasca penetesan pada kedua kelompokmengalami peningkatan secara klinis dibandingkan sebelum penetesan, namun tidak terdapatperbedaan bermakna secara statistik.Conclusions : Pemberian artificial tear mengandung sodium hialuronat 0,1% baik denganpengawet maupun tanpa pengawet selama 1 bulan memberikan peningkatan Schirmer test,TFBUT,OPI dan sitologi impresi sel goblet.

---

ABSTRACTObjectives: To evaluate the difference of quality of tears between glaucoma patients sufferingfrom dry eyes treated with 0.1% sodium hyaluronat eyedrops with preservativebenzalconiumchloride and those treated with 0.1% sodium hyaluronat eyedrops withoutpreservative.Methods: This is a randomized prospective study. Subjects were 30 glaucoma patients sufferingfrom dry eyes, whom later randomized into two groups. Group I was treated with artificial tearseye drops, which contained 0.1% sodium hyaluronat and benzalconium chloride preservative,whereas Group II was treated with artificial tears eye drops, which contained 0.1% sodiumhyaluronat without preservative for one-month duration. Before and after the treatment withartificial tears eyedrops, subjects of both groups were tested with Schirmer test, TFBUT, OPI, andimpression cytology.Results: The median of goblet cells in impression cytology after treatment with artificial tears eyedrops increased in group I (118, 15 ? 485) and group II (67, 0 ? 200), even though not statisticallysignificant. Mean TFBUT after treatment was also higher in Group I (14.45±7.85) and Group II(13.91±7.46), yet not statistically significant. Schirmer test and OPI results after treatment showeda clinical improvement in both groups, however no statistic result was found to be significant.Conclusions: Treatment with artifical tears eye drops containing 0.1% sodium hyaluronat with orwithout preservative for one month will improve Schirmer test, TFBUT, OPI, and goblet cellsimpressions cytology result on glaucoma patients suffering from dry eyes.;Objectives: To evaluate the difference of quality of tears between glaucoma patients sufferingfrom dry eyes treated with 0.1% sodium hyaluronat eyedrops with preservativebenzalconiumchloride and those treated with 0.1% sodium hyaluronat eyedrops withoutpreservative.Methods: This is a randomized prospective study. Subjects were 30 glaucoma patients sufferingfrom dry eyes, whom later randomized into two groups. Group I was treated with artificial tearseye drops, which contained 0.1% sodium hyaluronat and benzalconium chloride preservative,whereas Group II was treated with artificial tears eye drops, which contained 0.1% sodiumhyaluronat without preservative for one-month duration. Before and after the treatment withartificial tears eyedrops, subjects of both groups were tested with Schirmer test, TFBUT, OPI, andimpression cytology.Results: The median of goblet cells in impression cytology after treatment with artificial tears eyedrops increased in group I (118, 15 – 485) and group II (67, 0 – 200), even though not statisticallysignificant. Mean TFBUT after treatment was also higher in Group I (14.45±7.85) and Group II(13.91±7.46), yet not statistically significant. Schirmer test and OPI results after treatment showeda clinical improvement in both groups, however no statistic result was found to be significant.Conclusions: Treatment with artifical tears eye drops containing 0.1% sodium hyaluronat with orwithout preservative for one month will improve Schirmer test, TFBUT, OPI, and goblet cellsimpressions cytology result on glaucoma patients suffering from dry eyes., Objectives: To evaluate the difference of quality of tears between glaucoma patients sufferingfrom dry eyes treated with 0.1% sodium hyaluronat eyedrops with preservativebenzalconiumchloride and those treated with 0.1% sodium hyaluronat eyedrops withoutpreservative.Methods: This is a randomized prospective study. Subjects were 30 glaucoma patients sufferingfrom dry eyes, whom later randomized into two groups. Group I was treated with artificial tearseye drops, which contained 0.1% sodium hyaluronat and benzalconium chloride preservative,whereas Group II was treated with artificial tears eye drops, which contained 0.1% sodiumhyaluronat without preservative for one-month duration. Before and after the treatment withartificial tears eyedrops, subjects of both groups were tested with Schirmer test, TFBUT, OPI, andimpression cytology.Results: The median of goblet cells in impression cytology after treatment with artificial tears eyedrops increased in group I (118, 15 – 485) and group II (67, 0 – 200), even though not statisticallysignificant. Mean TFBUT after treatment was also higher in Group I (14.45±7.85) and Group II(13.91±7.46), yet not statistically significant. Schirmer test and OPI results after treatment showeda clinical improvement in both groups, however no statistic result was found to be significant.Conclusions: Treatment with artifical tears eye drops containing 0.1% sodium hyaluronat with orwithout preservative for one month will improve Schirmer test, TFBUT, OPI, and goblet cellsimpressions cytology result on glaucoma patients suffering from dry eyes.]"

"Penelitian ini merupakan uji eksperimental dengan tiga populasi berbeda dengan proses intervensi yang sama yaitu penetesan tropikamid 1% yang bertujuan untuk menilai fungsi dan struktur jaringan mata setelah penetesan tropikamid 1%. Sebanyak 90 subjek dibagi menjadi tiga kelompok berdasarkan usia dan diabetes melitus tipe 2. Dilakukan pemeriksaan diameter pupil, tajam penglihatan jauh dan dekat, tekanan intraokular, dan kedalaman bilik mata depan yang diukur pada menit ke-30, 60, dan 120 setelah penetesan. Hasil penelitian ini mendapatkan bahwa kelompok usia 20-40 tahun dan usia ≥ 60 tahun dengan DM kurang responsif terhadap tropikamid 1% dibanding usia ≥ 60 tahun non-DM.

---

This is a clinical experimental study in three different groups with one intervention. This study aimed to assess ocular functions and structures in normal and diabetic subjects. A total of 90 subjects were divided into three groups based on the description of age and present of type 2 diabetes mellitus. The evaluation of pupil diameter, visual acuity, intraocular pressure, and anterior chamber depth were assessed in 30, 60, and 120 minutes after 1% tropicamide instillation. The result is that in the 20-40 years old non-DM group and ≥ 60 years old with DM group are less responsive to 1% tropicamide than ≥ 60 years old non-DM group."

"[ABSTRAKTujuan: Untuk mengevaluasi pengaruh pemberian suplementasi Mirtogenol terhadap perubahan ketebalan lapisan serabut saraf retina dan lapang pandang pada pasien dengan glaukoma primer sudut terbuka (GPSTa) dengan tekanan intraokular (TIO) terkontrol.Metode: Penelitian ini merupakan penelitian prospektif, acak, tersamar ganda. Empat puluh satu pasien dengan GPSTa dengan TIO ≤ 18 mmHg diacak untuk mendapatkan Mirtogenol atau plasebo. Perubahan ketebalan RNFL dan MD lapang pandang diperiksa sebelum penelitian, 4 minggu serta 8 minggu setelah pemberian obat. Efek samping pengobatan ditanyakan kepada pasien selama penelitian.Hasil: Rerata ketebalan RNFL kelompok Mirtogenol mengalami penurunan sebesar -0.70±1.63 μm dari 87.29±19.39 μm di awal penelitian menjadi 86.58±19.43 μm setelah 8 minggu, namun perubahan yang terjadi tidak bermakna secara statistik (p=0.121). Rerata ketebalan RNFL kelompok plasebo mengalami penurunan sebesar -1.74±1.79 μm dari 97.14±17.19 μm di awal penelitianmenjadi 95.40±18.56 μm setelah 8 minggu, perubahan yang terjadi bermakna secara statistik (p< 0.001). Rerata MD lapang pandang kelompok Mirtogenol mengalami peningkatan 0.542±1.93 dB setelah 8 minggu sedangkan rerata MD lapang pandang kelompok plasebo mengalami penurunan sebesar -0.083±1.36 dB setelah 8 minggu. Namun perubahan rerata MD lapang pandang kedua kelompoktidak bermakna secara statistik (p>0.05). Selama penelitian tidak didapatkan adanya efek samping.Kesimpulan: Mirtogenol dapat mempertahankan ketebalan lapisan serabut saraf retina, dan MD lapang pandang pada pemberian Mirtogenol cenderung meningkat.

---

ABSTRACTObjective: To evaluate the effect of Mirtogenol towards the changes in retinal nerve fiber layer (RNFL) thickness and visual field in patients with primary open angle glaucoma (POAG) with controlled IOP.Methods: This is a prospective, double blind, randomized study. Forty one POAG patients with IOP ≤ 18 mmHg were randomly assigned to receive either Mirtogenol or placebo. Changes in RNFL thickness and mean deviation of visual fields were evaluated before the treatment, as well as 4 weeks and 8 weeks after the treatment. Patients were asked for any side effects during the treatment period.Results: The average RNFL thickness in the Mirtogenol group decreased 0.70±1.63 μm from 87.29±19.39 μm before the treatment to 86.58±19.43 μm after 8 weeks of treatment, however the change was not significant (p=0.121). The average RNFL thickness in the placebo group decreased -1.74±1.79 μm from 97.14±17.19 μm before the treatment to 95.40±18.56 μm after 8 weeks of treatment, the change was statistically significant (p< 0.001). The average MD of visual field in the Mirtogenol group increased 0.542±1.93 dB after 8 weeks oftreatment while the MD of visual field in the placebo group decreased 0.083 ± 1.36 dB after 8 weeks of treatment. Hoewever the changes in MD of visual field was not significant (p>0.05). No side effect was found throughout the study.Conclusions: Mirtogenol seemed to maintain retinal nerve fiber layer thickness and increased mean deviation of visual fields.;Objective: To evaluate the effect of Mirtogenol towards the changes in retinalnerve fiber layer (RNFL) thickness and visual field in patients with primary openangle glaucoma (POAG) with controlled IOP.Methods: This is a prospective, double blind, randomized study. Forty onePOAG patients with IOP ≤ 18 mmHg were randomly assigned to receive eitherMirtogenol or placebo. Changes in RNFL thickness and mean deviation of visualfields were evaluated before the treatment, as well as 4 weeks and 8 weeks afterthe treatment. Patients were asked for any side effects during the treatment period.Results: The average RNFL thickness in the Mirtogenol group decreased 0.70±1.63μmfrom87.29±19.39μmbeforethetreatmentto86.58±19.43μmafter8weeks of treatment, however the change was not significant (p=0.121). Theaverage RNFL thickness in the placebo group decreased -1.74±1.79 μm from97.14±17.19 μm before the treatment to 95.40±18.56 μm after 8 weeks oftreatment, the change was statistically significant (p< 0.001). The average MD ofvisual field in the Mirtogenol group increased 0.542±1.93 dB after 8 weeks oftreatment while the MD of visual field in the placebo group decreased 0.083±1.36dBafter8weeksoftreatment.HoeweverthechangesinMDofvisualfieldwasnotsignificant(p>0.05).Noside effectwasfound throughoutthestudy.Conclusions: Mirtogenol seemed to maintain retinal nerve fiber layer thickness and increased mean deviation of visual fields., Objective: To evaluate the effect of Mirtogenol towards the changes in retinalnerve fiber layer (RNFL) thickness and visual field in patients with primary openangle glaucoma (POAG) with controlled IOP.Methods: This is a prospective, double blind, randomized study. Forty onePOAG patients with IOP ≤ 18 mmHg were randomly assigned to receive eitherMirtogenol or placebo. Changes in RNFL thickness and mean deviation of visualfields were evaluated before the treatment, as well as 4 weeks and 8 weeks afterthe treatment. Patients were asked for any side effects during the treatment period.Results: The average RNFL thickness in the Mirtogenol group decreased 0.70±1.63μmfrom87.29±19.39μmbeforethetreatmentto86.58±19.43μmafter8weeks of treatment, however the change was not significant (p=0.121). Theaverage RNFL thickness in the placebo group decreased -1.74±1.79 μm from97.14±17.19 μm before the treatment to 95.40±18.56 μm after 8 weeks oftreatment, the change was statistically significant (p< 0.001). The average MD ofvisual field in the Mirtogenol group increased 0.542±1.93 dB after 8 weeks oftreatment while the MD of visual field in the placebo group decreased 0.083±1.36dBafter8weeksoftreatment.HoeweverthechangesinMDofvisualfieldwasnotsignificant(p>0.05).Noside effectwasfound throughoutthestudy.Conclusions: Mirtogenol seemed to maintain retinal nerve fiber layer thickness and increased mean deviation of visual fields.]"

"Tujuan: Membandingkan perubahan segmen anterior dan tekanan intraokular (TIO) antara tetes mata pilokarpin 2% dan laser iridotomi perifer (LIP) pada sudut tertutup primer. Desain: Penelitian ini merupakan uji klinis tunggal (one group pretest post-test design). Metode: Sebanyak 34 mata dari 29 subyek penelitian dengan sudut tertutup primer mendapatkan perlakuan tetes mata pilokarpin 2% selama 3-5 hari dan kemudian LIP. Seluruh subyek mendapatkan perlakuan yang sama. Dilakukan pemeriksaan TIO dan anterior segment optical coherence tomography (AS-OCT) sebanyak tiga kali, yaitu pada kondisi awal, 3-5 hari setelah pemberian tetes mata pilokarpin 2%, dan 1 minggu setelah laser iridotomi perifer. Parameter sudut yang dinilai adalah angle opening distance (AOD) dan trabecular-iris space area (TISA) yang diukur pada jarak 500 dan 750 μm dari scleral spur pada kuadran nasal dan temporal. Perubahan dihitung berdasarkan selisih antara nilai pasca pilokarpin 2% dan LIP dengan nilai awal. Hasil: Terdapat peningkatan nilai parameter sudut dan penurunan TIO baik pasca LIP maupun pasca tetes mata pilokarpin 2%. Terdapat penurunan nilai kedalaman bilik mata depan setelah tetes mata pilokarpin 2%. Kesimpulan: LIP membuka sudut lebih besar dibandingkan tetes mata pilokarpin 2%, namun tetes mata pilokarpin 2% menurunkan TIO lebih besar. Tetes mata pilokarpin 2% lebih mendangkalkan bilik mata depan dibandingkan LIP.

---

Purpose : To compare anterior segment and intraocular pressure changes between pilocarpine eye drops 2% and Laser Peripheral Iridotomy (LPI) in primary angle closure.

Methods : This was a clinical trial one group pretest post-test design. A total of 34 eyes of 29 subjects got treatment pilocarpine eye drops 2% for 3-5 days and then LPI. All subjects got the same treatment. Intraocular presssure and anterior segment optical coherence tomography examination was done three times, on the initial conditions, 3-5 days after administration of pilocarpine eye drops 2%, and 1 week after LPI. Angle parameters were the angle opening measured at a distance of 500 and 750 μm from the scleral spur on the nasal and temporal quadrants. The changes are calculated based on the difference between the post-pilocarpine 2% and LPI with initial values.

Result : There is an increase in the value of the angle parameters and reduction of IOP after the LPI and pilocarpine eye drops 2%. There is a decline in anterior chamber depth after pilocarpine eye drops 2%.

Conclusion : LPI widening the angle greater than pilocarpine eye drops 2%, but pilocarpine eye drops 2% lowering the IOP greater than LPI. Pilocarpine eye drops 2% shallowing the anterior chamber depth."

"ABSTRAKTujuanMengetahui efek jangka pendek pemberian anti-VEGF intravitreal bevacizumab (IVB) sebagai terapi ajuvan pada perubahan regresi neovaskularisasi iris dan perubahan tekanan intra okular (TIO) serta menilai hubungan antara kadar VEGF cairan akuos dengan perubahan TIO pada glaukoma neovaskular (NVG).DesainPeneitian ini merupakan uji klinis tunggalMetodeSebanyak 20 mata pada 18 subyek NVG dengan TIO tidak terkontrol dan neovaskularisasi iris dilakukan injeksi intravitreal bevacizumab 0.05mL(1.25mg) setelah dilakukan parasentesis sebelumnyaHasilInjeksi intravitreal bevacizumab secara klinis menyebabkan regresi neovaskularisasi iris pada seluruh pasien dengan NVG dan terjadi penurunan tekanan intra okular yang bermakna pada 1 minggu pasca injeksi (P=0.003). Kadar VEGF pre-injeksi yang tinggi berbanding lurus dengan TIO namun tidak bermakna secara statistik (r = 0.191, p=0.420)KesimpulanInjeksi intravitreal bevacizumab terbukti efektif dalam regresi neovaskularisasi iris dan menurunkan TIO pada pasien glaukoma neovaskular

---

ABSTRACTPurposeTo determine short term efficacy of intravitreal bevacizumab (IVB) against neovascularization regression and intraocular pressure (IOP) changes and itscorrelation with vascular endothelial growth factor.DesignSingle arm study clinical trialMethodTwenty eyes from 18 subjects of NVG patients with iris neovascularization and uncontrolled IOP received 0.05mL/1.25mg of IVB. Aqueous humor samples wereobtained through paracentesis just before IVBResultsIntravitreal bevacizumab injection can remarkably reduce iris neovascularization in NVG patients. There is significant IOP reduction a week after injection(p=0,003). High VEGF level before injection related linearly with IOP, but no statistically significance is found (r=0,191, p=0,420)ConclusionIntravitreal bevacizumab injection is proven effective to regress iris neovascularization and reduce IOP in NVG patients"

"ABSTRAKPenelitian ini bertujuan untuk menilai perubahan parameter bilik mata depan BMD dan penurunan tekanan intraokular TIO pasca fakoemulsifikasi lensa intraokular LIO pada pasien katarak senilis imatur dan katarak senilis imatur dengan glaukoma primer sudut terbuka GPSTa . Penelitian ini merupakan uji klinis intervensi non-random. Sebanyak 15 mata dengan katarak senilis imatur tanpa glaukoma dan 14 mata katarak dengan GPSTa dilakukan fakoemulsifikasi. Pemeriksaan TIO dan anterior segment optical coherence tomography AS-OCT dilakukan sebelum dan 1 bulan setelah fakoemulsifikasi. Parameter yang dinilai adalah central corneal thickness CCT , lens vault LV , angle opening distance AOD dan trabecular-iris space area TISA pada jarak 500 dan 750 ?m dari scleral spur kuadran nasal dan temporal. Pasca fakoemulsifikasi terjadi penurunan TIO sebesar 2.70 mmHg pada kelompok katarak tanpa glaukoma, dan sebesar 8.05 mmHg pada kelompok katarak dengan GPSTa. Penambahan nilai parameter sudut BMD signifikan terjadi pada kedua kelompok. Kesimpulan penelitian ini adalah fakoemulsifikasi dapat menurunkan TIO pada kedua kelompok, namun penurunan TIO lebih besar pada kelompok katarak dengan GPSTa dibandingkan dengan kelompok katarak tanpa glaukoma. Tidak terdapat korelasi penurunan TIO dengan penambahan parameter BMD. Kata Kunci: katarak senilis imatur, glaukoma sudut terbuka, tekanan intraokular, sudut bilik mata depan, fakoemulsifikasi.

---

ABSTRACTThis study evaluated the changes in the anterior chamber AC parameters and decrease in intraocular pressure IOP after phacoemulsification intraocular lens IOL in patients with senile immature cataract and senile immature cataract with primary open angle glaucoma POAG . A total of 15 eyes with senile cataract immature without glaucoma and 14 eyes with GPSTa performed phacoemulsification. Examination of IOP and anterior segment optical coherence tomography AS OCT performed before and 1 month after phacoemulsification. The parameters assessed were central corneal thickness CCT , lens vault LV , angle opening distance AOD and trabecular iris space area TISA at distances of 500 and 750 m from the scleral spur nasal and temporal quadrants. Post phacoemulsification occurs IOP reduction of 2.70 mmHg in the group cataract without glaucoma, and by 8.05 mmHg in the group with POAG. Increasing the value of the AC angle parameter significant in both groups. As conclusion phacoemulsification can lower IOP in both groups, the decrease in IOP greater in the group cataract with GPSTa than the group without glaucoma, however, there is no correlation IOP reduction with increased AC parameters.Keywords Senile immatur cataract, Primary open angle glaucoma, intraocular pressure, anterior chamber angle, phacoemulsification."

"ABSTRAKPajanan pestisida organofosfat terhadap mata dapat melalui pernafasan, pencernaan, absorbsi melalui kulit dan pajanan langsung pada mata. Efek toksik organofosfat akut yang utama pada mata adalah konstriksi pupil (miosis) melalui mekanisme menghambat aktivitas enzim kolinesterase di neuromuscular junction. Penelitian ini bertujuan untuk mengetahui hubungan penurunan diameter pupil dengan persentase penurunan aktivitas asetilkolinesterase plasma sesudah pajanan organofosfat pada petani penyemprot padi laki-laki. Penelitian ini menggunakan disain cross sectional dengan dua kali pengukuran sebelum dan sesudah penyemprotan pestisida di Desa X, Jawa Barat. Pengambilan sampel menggunakan metode cluster random sampling pada tingkat RT. Pengumpulan data dilakukan dengan wawancara menggunakan kuesioner, pemeriksaan fisis, pemriksaan darah dan pengamatan cara kerja. Pemeriksaan diameter pupil dan AChE plasma dilakukan sebelum dan sesudah penyemprotan. Dari 72 responden penelitian sebesar 64 responden (88,89%) mengalami penurunan diameter pupil baik secara unilateral maupun bilateral sesudah melakukan penyemprotan pestisida organofosfat. Nilai median perubahan aktivitas AChE plasma adalah 2,2 % dengan nilai minimum -4,26% dan maksimum 9,75%. Penurunan diameter pupil dan penurunan aktivitas asetilkolinesterase plasma secara statistik bermakna (paired t-test; p<0,001). Tidak ditemukan hubungan bermakna antara penurunan diameter pupil dengan persentase perubahan aktivitas asetilkolinesterase plasma (p=0,052). Pada penelitian ini tidak ditemukan hubungan antara penurunan diameter pupil dengan persentase perubahan asetilkolinesterase plasma dan faktor resiko lainnya seperti usia, IMT, masa kerja dan lama waktu penyemprotan pestisida. "